Mr. Rongjin Lin is currently the President of Center Ventures. Mr. Lin also holds several chief executive management roles in various biopharmaceutical companies and is highly influential in the Taiwan healthcare industry.
Mr. Lin is a highly-respected business leader in Taiwan and has been referred to as the Taiwanese biopharmaceutical industry “Lee Iacocca” due to his success at improving organizational structure, assisting corporate positioning and deploying managerial strategies. For over 20 years, Mr. Lin has actively led the transformation of Center Labs Inc. from a multiple dosage pharmaceutical factory to Taiwan’s largest professional oral solution pharmaceutical company. It has since evolved into a prominent biotechnology incubator platform in Asia, specializing in strategic investments and the resource integration. In recent years, Mr. Lin continues to invest in startups and emerging companies within the healthcare industry, including new drug development, antibody engineering and protein design, cell line generation, biosimilar drugs development and production, medical devices and agricultural biotech in the Greater China Region, Japan, Korea and other Asian countries. Up to now, he is proactively engaged in investing and creating synergistic biotech businesses, leading Taiwanese healthcare companies towards global markets.
Mr. Lin received B.S. degree in Pharmacy from Taipei Medical University, and was awarded the degree of Honorary Doctor in Medical by Taipei Medical University in 2010.